Vancouver, British Columbia– Precision NanoSystems (PNI), a biotechnology company pioneering innovative solutions for the development of genetic nanomedicines used in oncology, rare disease and infectious disease, announced today the launch of its Clinical Solutions service. PNI is offering this ne [...]
The Horizon ® system was designed to offer more versatility in one system, and more treatment options for patients. This clearance allows Magstim to market the 3-minute iTBS protocol. Clinicians have options to deliver treatments with the standard repetitive Transcranial Magnetic Stimulation (rTMS [...]
Seattle, WA, March 28, 2019 – RareCyte® announces the CyteFinder® II and CyteFinder II HT Instruments in conjunction with the American Association for Cancer Research Annual Meeting in Atlanta, March 29 through April 3. These next generation CyteFinder Instruments expand on RareCyte’s world class li [...]
March 20, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the healthcare industry, announced today the launch of its mSource®Predictive Plan, a new analytics feature that redefines strategic planning for purchased services by giving custo [...]
Cardiff, UK, and Baltimore, U.S., January 29, 2018 – TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, and WindMIL Therapeutics, a clinical stage oncology cell therapy company leveraging a proprietary platform to develop a novel class of cell [...]
MENLO PARK–(BUSINESS WIRE)—October 31, 2018—Akoya Biosciences (Akoya), a Telegraph Hill Partners (THP) company, has acquired PerkinElmer, Inc’s Quantitative Pathology Solutions (QPS) portfolio. Akoya was founded in 2015 to commercialize the CODEX® multiparameter tissue analysis technology developed [...]
SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has formally passed the registration application of Guangdong Food and Drug Administration, becoming the first CFDA approved MALDI [...]
The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas -- Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the CE marking and launch of the Quant [...]
Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a definitive agreement to acquire LyoGen LLC. Terms of the transaction were not disclosed [...]
First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and South San Francisco, CA, USA, April 26th 2018. Carterra™ Inc., a provider of innovative drug discovery [...]
